View highlights and coverage from leading international Cardiology congresses
Dr Wolfgang Linke (Professor and Chair of Physiology, University Hospital of Münster, Münster, Germany) kindly shared his thoughts on the titin gene TTNtv and dilated cardiomyopathy from the virtual ESC Congress 2021. Questions What is known about the correlation between variants in the titin gene (TTNtv) and the incidence of dilated cardiomyopathy (DCM), and what […]
Dr Hyo-Soo Kim (Interventional Cardiologist, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea) kindly shared his thoughts on the HOST-EXAM study and the effectiveness of clopidogrel versus aspirin for long-term maintenance after stenting, and the cost-effectiveness analysis from this data, from the virtual ESC Congress 2021. Questions What did the HOST-EXAM study teach us […]
Trudie Lobban (Founder and Trustee of the Arrhythmia Alliance, Chair of the HRC Organising Committee) introduces the A-A Heart Rhythm Congress 2021 (launching 3rd October 2021) and provides an overview of what to expect from this year’s meeting, why healthcare professionals should register, who can attend, and why the virtual platform will make this the […]
Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the fat attenuation index and its use in clinical decision making from the virtual ESC Congress 2021. Questions Can you tell us a little about the fat attenuation index (FAI) and how it can be […]
Prof. Charalambos Antoniades (Professor of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK) kindly shared his thoughts on the use of high-sensitivity C-reactive protein as a biomarker in clinical decision making, and the role of perivascular adipose tissue in the pathogenesis of atherosclerosis from the virtual ESC Congress 2021. Questions What is the […]
Dr Clara Chow (Professor of Medicine, Academic Director Westmead Applied Research Centre, University of Sydney, Sydney, Australia) kindly shared her thoughts on the limitations of current treatment paradigms for hypertension, the quad pill for hypertension, and the QUARTET study, from the virtual ESC Congress 2021. Questions What are the limitations of current treatment paradigms for […]
Dr Peter Smits (Interventional Cardiologist, Maasstad Hospital, Rotterdam, The Netherlands) kindly shared his thoughts on the major challenges in the treatment of patients at high bleeding risk after coronary stenting, with an overview of the recent key clinical trials involving percutaneous coronary intervention with stent deployment in patients at high bleeding risk, from the virtual ESC […]
Dr Roxana Mehran (Director of Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine, Mount Sinai Hospital, New York City, NY, USA) kindly shared her thoughts on the the PARADISE-MI trial (NCT02924727) from from the virtual ESC Congress 2021. Questions What has been the impact of angiotensin receptor-neprilysin inhibitors (ARNIs) on the treatment of […]
Prof. Stephen Nicholls (Professor of Cardiology, Monash University, Melbourne, Australia) kindly shared his thoughts on the impact of PCSK9 inhibitors on lipid-lowering therapy, the effects of statins on coronary atherosclerotic plaques and the HUYGENS study from the virtual ESC Congress 2021. Questions What has been the impact of PCSK9 inhibitors on lipid-lowering therapy, and what […]
Get the latest clinical insights from touchCARDIO
